Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$81
|
$229B |
3.5x |
7.9x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$24
|
$184B |
2.9x |
7.5x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€81
|
$123B |
2.3x |
7.9x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£15
|
$100B |
2.3x |
6.9x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 204
|
$74.2B |
4.7x |
14.0x |
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€207
|
$47.2B |
5.9x |
20.6x |
Wantai BioPharm
|
China |
Vaccines & Immunotherapies,
Pharma Diagnostics & Analytics
|
CNY 59
|
$10.0B |
N/A |
N/A |
Chongqing Zhifei
|
China |
Vaccines & Immunotherapies
|
CNY 22
|
$9.0B |
3.9x |
44.7x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$98
|
$7.4B |
2.8x |
-5.0x |
Alk-Abello
|
Denmark |
Vaccines & Immunotherapies
|
DKK 206
|
$7.1B |
7.6x |
26.6x |
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 2755
|
$5.0B |
11.4x |
35.9x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$24
|
$4.9B |
2.1x |
-1.3x |
Sinocelltech Group
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 60
|
$4.1B |
11.6x |
81.8x |
Hualan Biological Engineering
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 17
|
$3.9B |
5.8x |
15.1x |
BioKangtai
|
China |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
CNY 18
|
$3.1B |
7.2x |
23.9x |
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$3.0B |
36.0x |
N/A |
Bavarian Nordic
|
Denmark |
Vaccines & Immunotherapies
|
DKK 232
|
$2.6B |
2.7x |
7.8x |
Everest Medicines
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
HKD 58
|
$2.5B |
12.9x |
-51.0x |
AstraZeneca India
|
India |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
INR 8998
|
$2.5B |
N/A |
N/A |
Walvax Biotechnology
|
China |
Vaccines & Immunotherapies
|
CNY 12
|
$2.5B |
6.5x |
25.2x |
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$31
|
$2.4B |
N/A |
N/A |
SK Bioscience
|
South Korea |
Vaccines & Immunotherapies
|
KRW 51900
|
$2.4B |
6.7x |
-41.6x |
CStone Pharmaceuticals
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 10
|
$1.9B |
55.2x |
-65.7x |
GC Biopharma
|
South Korea |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
KRW 16214
|
$1.6B |
N/A |
N/A |
HBM Holdings
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 16
|
$1.5B |
11.9x |
19.5x |
Chengdu Kanghua
|
China |
Vaccines & Immunotherapies
|
CNY 82
|
$1.4B |
7.0x |
18.7x |
Immunocore Holdings
|
Germany |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€30
|
$1.3B |
N/A |
N/A |
Changchun BCHT
|
China |
Vaccines & Immunotherapies
|
CNY 23
|
$1.3B |
7.6x |
25.6x |
Hualan Biological Vaccine
|
China |
Vaccines & Immunotherapies
|
CNY 18
|
$1.3B |
8.0x |
8.8x |
Jinyu Bio-Technology Co.
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 9
|
$1.2B |
6.5x |
22.0x |
Cidara Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$67
|
$1.2B |
3209.7x |
N/A |
Keqian Biology
|
China |
Vaccines & Immunotherapies
|
CNY 19
|
$1.0B |
6.5x |
12.5x |
Celldex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$1000M |
224.9x |
-4.3x |
Novavax
|
United States of America |
Vaccines & Immunotherapies
|
$8
|
$929M |
1.0x |
3.7x |
Liaoning Chengda Biotech
|
China |
Vaccines & Immunotherapies
|
CNY 28
|
$905M |
3.9x |
12.4x |
Nektar Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$49
|
$852M |
14.5x |
-8.5x |
Valneva
|
France |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
€4
|
$807M |
3.7x |
-34.7x |
CureVac
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$5
|
$785M |
3.4x |
-40.8x |
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$769M |
2.4x |
40.0x |
Luzhu Biotech
|
Hong Kong |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
HKD 25
|
$607M |
243.4x |
-31.0x |
Renata
|
Bangladesh |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BDT 491
|
$604M |
N/A |
N/A |
Recbio
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 8
|
$585M |
N/A |
-9.3x |
Shanghai Hile Bio-Tech
|
China |
Vaccines & Immunotherapies
|
CNY 7
|
$581M |
N/A |
N/A |
Allergy Therapuetics
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$565M |
7.0x |
-23.4x |
Immunome
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$561M |
66.7x |
-2.4x |
Compass Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$542M |
2140.0x |
N/A |
Upstream Bio
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$17
|
$513M |
198.1x |
-3.8x |
GlaxoSmithKline Pakistan
|
Pakistan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
PKR 412
|
$441M |
2.0x |
N/A |
Northwest Biotherapeutics
|
United States of America |
Vaccines & Immunotherapies
|
$0
|
$440M |
N/A |
N/A |
Arcus Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$12
|
$430M |
1.7x |
-1.2x |
Ocugen
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Genomics & Personalized Medicine
|
$1
|
$381M |
103.9x |
N/A |
Corvus Pharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$365M |
663.4x |
N/A |
Medigen Vaccine Biologics
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 38
|
$357M |
18.1x |
-1217.4x |
Kamada
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 23
|
$337M |
1.9x |
8.0x |
AnaptysBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$20
|
$313M |
3.0x |
-3.5x |
Faron Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£2
|
$290M |
330011.9x |
-11.6x |
Adimmune
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 18
|
$280M |
N/A |
N/A |
Ourofino
|
Brazil |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BRL 22
|
$271M |
1.3x |
6.7x |
Invivyd
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$236M |
5.3x |
-2.7x |
CHO Pharma
|
Taiwan |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
TWD 39
|
$198M |
N/A |
N/A |
Tevogen Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$181M |
N/A |
N/A |
CytomX Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$177M |
1.7x |
7.8x |
Candel Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$174M |
N/A |
-4.9x |
Transgene
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€1
|
$170M |
4.9x |
-145.6x |
Instil Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$167M |
N/A |
N/A |
Acepodia
|
Taiwan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TWD 17
|
$163M |
N/A |
N/A |
Vir Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$162M |
5.4x |
-0.3x |
Elicio Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$158M |
N/A |
N/A |
Greenwich LifeSciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$12
|
$156M |
N/A |
N/A |
Immatics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$152M |
1.7x |
-1.0x |
Turk İlaç
|
Turkey |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TRY 23
|
$144M |
N/A |
N/A |
OSE Immunotherapeutics
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€6
|
$143M |
2.1x |
5.8x |
Vaxcell-Bio
|
South Korea |
Vaccines & Immunotherapies
|
KRW 9400
|
$135M |
N/A |
N/A |
I-MAB
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$133M |
N/A |
N/A |
Celularity
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine,
Vaccines & Immunotherapies
|
$2
|
$128M |
N/A |
N/A |
Scancell
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$127M |
29.2x |
-7.3x |
Genelux
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$122M |
52428.2x |
-4.9x |
Tonix Pharmaceuticals
|
United States of America |
Vaccines & Immunotherapies
|
$28
|
$118M |
12.2x |
N/A |
Oncolytics Biotech
|
United States of America |
Vaccines & Immunotherapies
|
$1
|
$116M |
N/A |
-3.9x |
Replimune Group
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$116M |
47.5x |
-0.4x |
TuHURA Biosciences
|
United States of America |
Vaccines & Immunotherapies
|
$2
|
$112M |
N/A |
N/A |
Cartesian Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$108M |
8.6x |
N/A |
IO Biotech
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$101M |
N/A |
-1.1x |
Anixa Biosciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$100M |
N/A |
N/A |
AC Immune
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$96.4M |
7.8x |
N/A |
LakeShore Biopharma Co
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$87.4M |
1.0x |
994.7x |
Inovio Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$84.3M |
669.3x |
N/A |
Atara Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$12
|
$79.2M |
0.6x |
11.0x |
Liminatus Pharma
|
United States of America |
Vaccines & Immunotherapies
|
$2
|
$69.3M |
N/A |
N/A |
MiNK Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$14
|
$68.4M |
N/A |
N/A |
Coya Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$65.2M |
16.1x |
N/A |
Allogene Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$61.3M |
6832.6x |
-0.3x |
Immix Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$57.7M |
N/A |
-2.5x |
Imugene
|
Australia |
Vaccines & Immunotherapies
|
AUD 0
|
$51.7M |
N/A |
N/A |
Medicenna Therapeutics
|
Canada |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CAD 1
|
$48.6M |
664.3x |
N/A |
Adagene
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$43.5M |
13.5x |
-1.4x |
European Medical
|
Belgium |
Vaccines & Immunotherapies
|
€5
|
$41.3M |
N/A |
N/A |
PDS Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$41.2M |
N/A |
-1.0x |
Eledon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$40.5M |
N/A |
N/A |
Adaptimmune Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$40.3M |
0.6x |
-0.7x |